Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 29 symbols : GILD save search
Gilead’s Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be Highlighted With New Data at SABCS
Published: 2021-11-29 (Crawled : 16:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 2.1K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
treatment cancer negative breast cancer
Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 2.1K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
AMZN S | $177.23 1.49% 2.0% 28M
|
Retail Trade
|
| O: 1.2%
H: 0.0%
C: 0.0%
liver collaboration
G1 Therapeutics Announces Initiation of New Phase 2 Trial of Trilaciclib in Combination with the Antibody-Drug Conjugate (ADC)
Published: 2021-11-29 (Crawled : 13:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 2.1K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GTHX | $4.1 -0.24% -0.24% 26K
|
Health Technology
|
| O: 0.75%
H: 0.82%
C: -6.28%
phase 2 trilaciclib antibody drug trial therapeutics
G1 Therapeutics Announces Initiation of New Phase 2 Trial of Trilaciclib in Combination with the Antibody-Drug Conjugate (ADC), Trodelvy® (Sacituzumab Govitecan-Hziy)
Published: 2021-11-29 (Crawled : 12:00) - globenewswire.com
GILD | $66.95 0.29% 0.28% 2.1K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GTHX | $4.1 -0.24% -0.24% 26K
|
Health Technology
|
| O: 0.75%
H: 0.82%
C: -6.28%
trodelvy phase 2 trilaciclib antibody drug trial therapeutics
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.